<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30176813</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>10</Month>            <Day>31</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Electronic">            <Journal>                <ISSN IssnType="Electronic">1471-2407</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>18</Volume>                    <Issue>1</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                        <Day>03</Day>                    </PubDate>                </JournalIssue>                <Title>BMC cancer</Title>                <ISOAbbreviation>BMC Cancer</ISOAbbreviation>            </Journal>            <ArticleTitle>The impact of mammography screening programmes on incidence of advanced breast cancer in Europe: a literature review.</ArticleTitle>            <Pagination>                <MedlinePgn>860</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12885-018-4666-1</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Observational studies have reported conflicting results on the impact of mammography service screening programmes on theÂ advanced breast cancer rate (ABCR), a correlation that was firmly established in randomized controlled trials. We reviewed and summarized studies of the effect of service screening programmes in the European Union on ABCR and discussed their limitations.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">The PubMed database was searched for English language studies published between 01-01-2000 and 01-06-2018. After inspection of titles and abstracts, 220 of the 8644 potentially eligible papers were considered relevant. Their abstracts were reviewed by groups of two authors using predefined criteria. Fifty studies were selected for full paper review, and 22 of these were eligible. A theoretical framework for their review was developed. Review was performed using a ten-point checklist of the methodological caveats in the analysis of studies of ABCR and a standardised assessment form designed to extract quantitative and qualitative information.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Most of the evaluable studies support a reduction in ABCR following the introduction of screening. However, all studies were challenged by issues of design and analysis which could at least potentially cause bias, and showed considerable variation in the estimated effect. Problems were observed in duration of follow-up time, availability of reliable reference ABCR, definition of advanced stage, temporal variation in the proportion of unknown-stage cancers, and statistical approach.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We conclude that much of the current controversy on the impact of service screening programmes on ABCR is due to observational data that were gathered and/or analysed with methodological approaches which could not capture stage effects in full. Future research on this important early indicator of screening effectiveness should focus on establishing consensus in the correct methodology.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Broeders</LastName>                    <ForeName>M J M</ForeName>                    <Initials>MJM</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-8741-8148</Identifier>                    <AffiliationInfo>                        <Affiliation>Radboud Institute for Health Sciences, Radboud university medical center, PO Box 9101, 6500, HB, Nijmegen, The Netherlands. mireille.broeders@radboudumc.nl.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Dutch Expert Centre for Screening, Nijmegen, The Netherlands. mireille.broeders@radboudumc.nl.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Allgood</LastName>                    <ForeName>P</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Duffy</LastName>                    <ForeName>S W</ForeName>                    <Initials>SW</Initials>                    <AffiliationInfo>                        <Affiliation>Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hofvind</LastName>                    <ForeName>S</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Registry of Norway, Oslo, Norway.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Nagtegaal</LastName>                    <ForeName>I D</ForeName>                    <Initials>ID</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Paci</LastName>                    <ForeName>E</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Retired, Clinical and Descriptive Epidemiology Unit, Cancer Research and Prevention Institute (ISPO), Florence, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Moss</LastName>                    <ForeName>S M</ForeName>                    <Initials>SM</Initials>                    <AffiliationInfo>                        <Affiliation>Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bucchi</LastName>                    <ForeName>L</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Romagna Cancer Registry, Romagna Cancer Institute (Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRST, IRCCS), Meldola, Forli, Italy.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D016454">Review</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>03</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>BMC Cancer</MedlineTA>            <NlmUniqueID>100967800</NlmUniqueID>            <ISSNLinking>1471-2407</ISSNLinking>        </MedlineJournalInfo>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2005 Jan 17;92(1):156-61</RefSource>                <PMID Version="1">15597100</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Med Screen. 2009;16(4):186-92</RefSource>                <PMID Version="1">20054093</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Control. 2004 Jul-Aug;11(4):222-30</RefSource>                <PMID Version="1">15284713</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2016 Mar 1;114(5):590-6</RefSource>                <PMID Version="1">26835975</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Med Screen. 2012;19 Suppl 1:14-25</RefSource>                <PMID Version="1">22972807</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Causes Control. 1999 Oct;10(5):333-7</RefSource>                <PMID Version="1">10530601</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Med Screen. 2012;19 Suppl 1:5-13</RefSource>                <PMID Version="1">22972806</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Intern Med. 2012 Apr 3;156(7):491-9</RefSource>                <PMID Version="1">22473436</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2013 Jun 1;119(11):2022-8</RefSource>                <PMID Version="1">23504860</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 2003 Aug;39(12):1776-82</RefSource>                <PMID Version="1">12888374</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):45-51</RefSource>                <PMID Version="1">16434585</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMJ. 2014 Feb 11;348:g366</RefSource>                <PMID Version="1">24519768</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2004 Apr 1;100(7):1337-44</RefSource>                <PMID Version="1">15042665</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 2017 Apr;75:109-116</RefSource>                <PMID Version="1">28222306</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 1989 Jun;59(6):954-8</RefSource>                <PMID Version="1">2736233</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Public Health. 2008 Jan 28;8:38</RefSource>                <PMID Version="1">18226204</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2011 Apr 6;103(7):585-97</RefSource>                <PMID Version="1">21350218</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Acta Oncol. 2014 Apr;53(4):433-44</RefSource>                <PMID Version="1">24495043</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast J. 2015 Jan-Feb;21(1):13-20</RefSource>                <PMID Version="1">25413699</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2011 Aug;22(8):1726-35</RefSource>                <PMID Version="1">21252058</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2009 Jan;113(1):173-9</RefSource>                <PMID Version="1">18259855</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2004 Aug 31;91(5):861-7</RefSource>                <PMID Version="1">15292936</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMJ. 2017 Dec 5;359:j5224</RefSource>                <PMID Version="1">29208760</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2016 Oct 13;375(15):1438-1447</RefSource>                <PMID Version="1">27732805</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Intern Med. 2017 Mar 7;166(5):313-323</RefSource>                <PMID Version="1">28114661</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Causes Control. 2002 Mar;13(2):137-45</RefSource>                <PMID Version="1">11936820</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2007 Jun 1;109(11):2205-12</RefSource>                <PMID Version="1">17471486</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2013 Feb;137(3):653-63</RefSource>                <PMID Version="1">23263739</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2012 Jan 09;14(1):R10</RefSource>                <PMID Version="1">22230363</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Med Screen. 2017 Dec;24(4):189-194</RefSource>                <PMID Version="1">27810986</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer Prev. 2012 May;21(3):217-21</RefSource>                <PMID Version="1">22314850</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2012 Aug;135(1):291-9</RefSource>                <PMID Version="1">22833199</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2009 Dec 10;27(35):5919-23</RefSource>                <PMID Version="1">19884547</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Epidemiol. 2016 Oct;44:44-51</RefSource>                <PMID Version="1">27470937</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Radiol Clin North Am. 1992 Jan;30(1):187-210</RefSource>                <PMID Version="1">1732926</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Public Health. 2014 Dec;24(6):1017-22</RefSource>                <PMID Version="1">24596400</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Causes Control. 2001 Apr;12(3):249-55</RefSource>                <PMID Version="1">11405330</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2002 Jul 1;87(1):65-9</RefSource>                <PMID Version="1">12085258</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2012 Nov 22;367(21):1998-2005</RefSource>                <PMID Version="1">23171096</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2011 Apr 1;117(7):1360-8</RefSource>                <PMID Version="1">21425135</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast. 2018 Apr;38:107-113</RefSource>                <PMID Version="1">29306771</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Acta Oncol. 2008;47(2):225-31</RefSource>                <PMID Version="1">17851868</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Med Screen. 2002;9(3):120-4</RefSource>                <PMID Version="1">12370323</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 1999 Jun 11;81(6):877-80</RefSource>                <PMID Version="1">10362133</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2017 Dec 20;12(12):e0188947</RefSource>                <PMID Version="1">29261685</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Med Screen. 2012;19 Suppl 1:26-32</RefSource>                <PMID Version="1">22972808</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D001940" MajorTopicYN="N">Breast</DescriptorName>                <QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D055088" MajorTopicYN="Y">Early Detection of Cancer</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005060" MajorTopicYN="N">Europe</DescriptorName>                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008327" MajorTopicYN="N">Mammography</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Advanced stage</Keyword>            <Keyword MajorTopicYN="N">Breast cancer</Keyword>            <Keyword MajorTopicYN="N">Mammography</Keyword>            <Keyword MajorTopicYN="N">Review</Keyword>            <Keyword MajorTopicYN="N">Screening</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2017</Year>                <Month>10</Month>                <Day>01</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>11</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>5</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>5</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>11</Month>                <Day>1</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30176813</ArticleId>            <ArticleId IdType="doi">10.1186/s12885-018-4666-1</ArticleId>            <ArticleId IdType="pii">10.1186/s12885-018-4666-1</ArticleId>            <ArticleId IdType="pmc">PMC6122725</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>